Analyst Ratings

Date	Action	Analyst	Rating	Target
Jun-15-26	Reiterated	Piper Sandler	Overweight	$115 → $100
May-08-26	Reiterated	Needham	Buy	$112 → $117
May-08-26	Reiterated	Wells Fargo	Overweight	$78 → $103
Feb-25-26	Reiterated	Truist Financial		$105 → $115
Jan-30-26	Upgrade	Needham	Hold → Buy	$71 → $112
Jan-26-26	Initiated	TD Cowen	Buy	$110
Jan-09-26	Reiterated	Canaccord Genuity	Buy	$105 → $112
Jan-08-26	Reiterated	Piper Sandler	Overweight	$80 → $115
Dec-17-25	Reiterated	Canaccord Genuity	Buy	$90 → $105
Dec-17-25	Reiterated	RBC Capital	Outperform	$88 → $100

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023
Total Revenue	3,100	2,939	2,519	Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A	996	958	1,035
Gross Profit	2,105	1,981	1,484
Selling, General and Administrative Excl. Other	1,372	1,316	981
Research and Development	189	185	164
Other Operating Expense	-2	0	173
Operating Income	547	480	166
Interest Expense	0	0	4
Unusual Expense	—	—	—
Non-Operating Income (Expense)	-52	-130	-54
Net Income Before Taxes	663	610	121
Income Taxes	76	72	18
Consolidated Net Income	587	538	103
Net Income From Continuing Operations	587	538	103
Net Income	587	538	103
EPS (Recurring)	4.35	3.98	0.76
EPS (Basic, Before Extraordinaries)	4.35	3.98	0.76
EPS (Diluted)	4.28	3.92	0.75
EBITDA	879	730	474
Other After Tax Adjustments	—	—	—
Stock Option Compensation Expense	—	—	—
Price To Earnings Ratio	18.51	22.27	—
Price To Sales Ratio	3.45	4.01	—
Gross Margin	67.90	67.40	58.91
Operating Margin	17.65	16.33	6.59
Net Margin	18.94	18.31	4.09
Shares Outstanding	135	135	136
Market Capitalization	10,696	11,787	—
Operating Lease Expense	—	—	—

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Davidar David D	Director	Jun 05 '26	Sale	80.76	25,000	2,019,073	510,175	Jun 09 12:00 AM
Davidar David D	Director	Jun 05 '26	Option Exercise	26.27	50,000	1,313,500	535,175	Jun 09 12:00 AM
RHOADS ANN D	Director	Jun 04 '26	Option Exercise	26.27	50,000	1,313,500	40,384	Jun 08 12:00 AM
Huller Kelly	EVP, GC, Corporate Secretary	Feb 25 '26	Option Exercise	43.58	40,000	1,743,200	20,000	Feb 27 12:00 AM
Huller Kelly	EVP, GC, Corporate Secretary	Feb 25 '26	Sale	94.50	20,000	1,890,000	0	Feb 27 12:00 AM
Huller Kelly	EVP, GC, Corporate Secretary	Feb 12 '26	Option Exercise	45.64	20,000	912,800	10,000	Feb 17 12:00 AM
Huller Kelly	EVP, GC, Corporate Secretary	Feb 12 '26	Sale	87.67	10,000	876,700	0	Feb 17 12:00 AM
Kline Kyle	Senior Vice President, CFO	Dec 01 '25	Option Exercise	60.31	42,084	2,538,150	18,542	Jan 13 12:00 AM
Kline Kyle	Senior Vice President, CFO	Jan 08 '26	Option Exercise	51.87	7,188	372,842	3,906	Jan 12 12:00 AM
Kline Kyle	Senior Vice President, CFO	Jan 08 '26	Sale	101.10	3,594	363,353	0	Jan 12 12:00 AM
Norwalk Leslie V	Director	Jan 08 '26	Sale	101.10	2,000	202,200	10,419	Jan 12 12:00 AM
Norwalk Leslie V	Director	Dec 12 '25	Sale	88.85	4,000	355,400	12,419	Dec 16 12:00 AM
Paul David C	Executive Chairman	Dec 08 '25	Option Exercise	25.52	68,750	1,754,500	60,417	Dec 10 12:00 AM
Kline Kyle	Senior Vice President, CFO	Dec 01 '25	Sale	90.00	18,542	1,668,780	0	Dec 03 12:00 AM
Huller Kelly	SVP, GC, Corporate Secretary	Nov 25 '25	Option Exercise	25.96	15,000	389,400	7,500	Nov 28 12:00 AM


Market Cap	10.17B	Forward P/E	15.40	EPS next Y	5.15	Insider Trans	-	Shs Float	-	Perf Month	-0.88%


Enterprise Value	9.73B	PEG	0.08	EPS next Q	1.12	Inst Own	-	Short Float	-	Perf Quarter	-8.19%


Income	584.86M	P/S	3.28	EPS this Y	10.82%	Inst Trans	-	Short Ratio	-	Perf Half Y	-7.65%


Sales	3.10B	P/B	2.16	EPS next Y	8.47%	ROA	10.79%	Short Interest	-	Perf YTD	-9.25%


Book/sh	-	P/C	13.11	EPS next 5Y	9.34%	ROE	13.04%	52W High	101.39 -21.86%	Perf Year	36.27%


Cash/sh	-	P/FCF	16.94	EPS past 3/5Y	-	ROIC	9.72%	52W Low	51.79 52.98%	Perf 3Y	-


Dividend Est.	-	EV/EBITDA	11.05	Sales past 3/5Y	42.16% 30.08%	Gross Margin	67.86%	Volatility	2.18% 2.02%	Perf 5Y	-


Dividend TTM	-	EV/Sales	3.14	EPS Y/Y TTM	492.00%	Oper. Margin	17.62%	ATR (14)	2.72	Perf 10Y	-


Dividend Ex-Date	-	Quick Ratio	2.95	Sales Y/Y TTM	23.06%	Profit Margin	18.92%	RSI (14)	46.20	Recom	2.11


Dividend Gr. 3/5Y	-	Current Ratio	4.56	EPS Q/Q	64.71%	SMA20	-1.54%	Beta	1.02	Target Price	109.50


Payout	0.00%	Debt/Eq	0.02	Sales Q/Q	27.09%	SMA50	-6.75%	Rel Volume	2.25	Prev Close	75.42


Employees	5,300	LT Debt/Eq	0.02	Earnings	Aug 06	SMA200	-2.07%	Avg Volume	1.61M	Price	79.23


IPO Date	Aug 03, 2012	Option/Short	Yes / Yes	EPS/Sales Surpr.	21.74% 2.70%	Net Debt/EBITDA	-0.51	Volume	3,621,720	Change	5.05%

GMED